These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19602040)

  • 1. Let-7 repression leads to HMGA2 overexpression in uterine leiomyosarcoma.
    Shi G; Perle MA; Mittal K; Chen H; Zou X; Narita M; Hernando E; Lee P; Wei JJ
    J Cell Mol Med; 2009 Sep; 13(9B):3898-905. PubMed ID: 19602040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma.
    Peng Y; Laser J; Shi G; Mittal K; Melamed J; Lee P; Wei JJ
    Mol Cancer Res; 2008 Apr; 6(4):663-73. PubMed ID: 18403645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling and functional analyses of microRNAs and their target gene products in human uterine leiomyomas.
    Zavadil J; Ye H; Liu Z; Wu J; Lee P; Hernando E; Soteropoulos P; Toruner GA; Wei JJ
    PLoS One; 2010 Aug; 5(8):e12362. PubMed ID: 20808773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2.
    Park SM; Shell S; Radjabi AR; Schickel R; Feig C; Boyerinas B; Dinulescu DM; Lengyel E; Peter ME
    Cell Cycle; 2007 Nov; 6(21):2585-90. PubMed ID: 17957144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An HMGA2-p62-ERα axis regulates uterine leiomyomas proliferation.
    Liu B; Chen G; He Q; Liu M; Gao K; Cai B; Qu J; Lin S; Geng A; Li S; Wang K; Mao Z; Wan X; Yan Q
    FASEB J; 2020 Aug; 34(8):10966-10983. PubMed ID: 32592217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NNMT overexpression is an adverse prognostic factor in uterine leiomyosarcoma.
    Türkmen O; Müftüoğlu KH; Dinçer N; Çelik ZE; Akar Inan S
    Turk J Med Sci; 2024; 54(4):804-810. PubMed ID: 39295619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs involved in the HMGA2 deregulation and its co-occurrence with MED12 mutation in uterine leiomyoma.
    Mello JBH; Barros-Filho MC; Abreu FB; Cirilo PDR; Domingues MAC; Pontes A; Rogatto SR
    Mol Hum Reprod; 2018 Nov; 24(11):556-563. PubMed ID: 30376129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells.
    de Almeida BC; Garcia N; Maffazioli G; dos Anjos LG; Baracat EC; Carvalho KC
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
    Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
    Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let-7 microRNA and HMGA2 levels of expression are not inversely linked in adipocytic tumors: analysis of 56 lipomas and liposarcomas with molecular cytogenetic data.
    Bianchini L; Saâda E; Gjernes E; Marty M; Haudebourg J; Birtwisle-Peyrottes I; Keslair F; Chignon-Sicard B; Chamorey E; Pedeutour F
    Genes Chromosomes Cancer; 2011 Jun; 50(6):442-55. PubMed ID: 21412931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: implications for HMGA2 expression.
    Agostini A; Brunetti M; Davidson B; Tropé CG; Heim S; Panagopoulos I; Micci F
    Oncotarget; 2017 Mar; 8(13):21554-21560. PubMed ID: 28423547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA.
    Zhang K; Gao H; Wu X; Wang J; Zhou W; Sun G; Wang J; Wang Y; Mu B; Kim C; Chu P; Ho DM; Ann DK; Wong TT; Yen Y
    Clin Cancer Res; 2014 Mar; 20(5):1179-89. PubMed ID: 24423609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma.
    Yang Q; Bariani MV; Falahati A; Khosh A; Lastra RR; Siblini H; Boyer TG; Al-Hendy A
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma--differences in histological subtypes.
    Eide HA; Halvorsen AR; Bjaanæs MM; Piri H; Holm R; Solberg S; Jørgensen L; Brustugun OT; Kiserud CE; Helland Å
    BMC Cancer; 2016 Feb; 16():71. PubMed ID: 26858029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2, and FH mutations.
    Xie J; Ubango J; Ban Y; Chakravarti D; Kim JJ; Wei JJ
    Genes Chromosomes Cancer; 2018 Oct; 57(10):485-494. PubMed ID: 29790226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease.
    Klemke M; Meyer A; Nezhad MH; Bartnitzke S; Drieschner N; Frantzen C; Schmidt EH; Belge G; Bullerdiek J
    Genes Chromosomes Cancer; 2009 Feb; 48(2):171-8. PubMed ID: 18980243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGFR4 promotes nuclear localization of GABP to inhibit cell apoptosis in uterine leiomyosarcoma.
    Zhang P; Zhang H; Wang Y
    Cell Tissue Res; 2021 Feb; 383(2):865-879. PubMed ID: 33151453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas.
    Anderson SE; Nonaka D; Chuai S; Olshen AB; Chi D; Sabbatini P; Soslow RA
    Int J Gynecol Cancer; 2006; 16(2):849-53. PubMed ID: 16681772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas.
    Wang T; Zhang X; Obijuru L; Laser J; Aris V; Lee P; Mittal K; Soteropoulos P; Wei JJ
    Genes Chromosomes Cancer; 2007 Apr; 46(4):336-47. PubMed ID: 17243163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant let7a/HMGA2 signaling activity with unique clinical phenotype in
    Chen CC; You JY; Lung J; Huang CE; Chen YY; Leu YW; Ho HY; Li CP; Lu CH; Lee KD; Hsu CC; Gau JP
    Haematologica; 2017 Mar; 102(3):509-518. PubMed ID: 28057739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.